Post-Market Observational Study of the WINX Sleep Therapy for the Treatment of Obstructive Sleep Apnea (OSA)

ApniCure, Inc.1,000 enrolled

Overview

The objective of the Study is to observe the use and utility of the Winx Sleep Therapy System in a clinical practice, for the treatment of patients with obstructive sleep apnea (OSA).

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Obstructive Sleep Apnea

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Exclusion Criteria * Has a severe respiratory disorder, such as severe lung disease, pneumothorax, etc. * Has loose teeth or advanced periodontal disease. * Is under the age of 18.

Locations (2)

St. Petersburg Sleep Disorders Center

St. Petersburg, Florida, United States

RECRUITING

Sleep Medicine Associates of Texas (SMAT)

Dallas, Texas, United States

RECRUITING

Central Contacts

Lawrence Siegel, MD

CONTACT

650-361-9399 lsiegel@apnicure.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.